inClinico

?? Stay Ahead with AI-Powered Drug Discovery! ???? At Insilico Medicine, we’re transforming drug discovery with Pharma.AI. Be sure to follow our Pharma.AI platforms to stay updated on the latest breakthroughs, partnerships, conference presentations, and innovations in AI-driven biologics, small molecule drug design, target discovery, and more. Be sure to follow below ?? ?? Chemistry42 – AI-powered generative chemistry for drug design ?? Generative Biologics – Advancing biologics discovery with AI ?? PandaOmics – AI-driven target discovery and disease insights ?? inClinico – Predicting clinical trial success with AI Follow our platforms to stay informed, connect with experts, and shape the future of AI in pharma! #AIinDrugDiscovery #PharmaAI #GenerativeAI #TargetDiscovery #ClinicalAI #InsilicoMedicine #FollowUs

?? Big things are happening at Insilico Medicine! We’ve recently announced our latest $550 million deal with Menarini Stemline, marking our third AI-discovered drug to be out-licensed. But what does this mean for YOU? ?? Whether you’re interested in strategic collaborations or licensing our AI platforms, we’re here to help you supercharge your drug discovery process. ?? Feel free to DM me or drop us an email, I’m happy to discuss and explore how we can transform your research! ?? ?? Explore more: ?? Insilico Medicine Website: https://insilico.com/ ?? Clinical Pipeline: https://lnkd.in/g5UnVWii ?? Pharma.AI Platforms: https://pharma.ai/ ?? Peer-reviewed Publications: https://lnkd.in/dqWgSD_Z ?? Academic Grant Opportunities: https://lnkd.in/dDtfp_v6 ?? Generative AI for Environmental Sustainability Consortium: https://lnkd.in/dfpEcPSP ?? Explore Insilico Medicine’s Pharma.AI Suite: ?? PandaOmics: https://lnkd.in/dvnhJcP2 ?? Chemistry42: https://lnkd.in/dayMCYBk ?? Generative Biologics: https://lnkd.in/dM_3dVwZ ?? Precious3GPT: https://pharma.ai/precious ?? inClinico: https://lnkd.in/dN5Xmwx2

Happy Holidays from the inClinico Team!

Our dear customers, partners, and collaborators using the Pharma.AI platform. Our platform teams in charge of PandaOmics, Chemistry42, inClinico, Precious3GPT, DORA, Science42 Sustainability Consortium and the foundational models salute you ?? and wish you Happy Holidays and Happy New Year! ??

Black Friday Special from Insilico Medicine?? Science42: #DORA is now available to new users for 50% off, available through December 3. Unlock the future of scientific writing with DORA (Draft Outline Research Assistant), an advanced #AI-driven tool designed to streamline the process of drafting academic papers and other related documents. Get started today! Only available for a limited time: https://bit.ly/4fZcT88 #DocumentGeneration #GenerativeAI #Publications #ConferenceAbstracts #ReviewWriting #Blogs

Startup?Insilico Medicine?offers a software program called InClinico, which uses #generativeAI to?predict outcomes of Phase II clinical trials, which is the part where initial efficacy is determined. The company says the technology can predict with 79% accuracy how a Phase II trial will play out.?

Nice to see inClinico mentioned - it was a lot of work over many years https://lnkd.in/gNKUVu7h

?? Did you know Malm? is famous for having the BEST falafels in Sweden? Well, here’s another exciting fact: Insilico Medicine is making our first-ever appearance at #NLSDays2024, and we’re kicking it off with a bang! ?? Petrina Kamya, Ph.D., Global Head of AI Platforms and President of Insilico Medicine Canada, will be part of the opening address panel, "Unveiling the Future: Life Science Industry and Healthcare in the Age of AI," alongside: ? Mala Valroy - Deep Tech Investment Manager, Industrifonden ? Peder Blomgren - VP and Head of Data Office, AstraZeneca ? Claire Riches - VP, Clinical Solutions, Citeline Attending #NLSDays ? Let’s connect in person! Drop a comment or DM me to chat about: ?? our Pharma.AI platforms (PandaOmics, Chemistry42, Generative Biologics, inClinico) and how it can accelerate your drug discovery initiatives ?? our internal assets that are ready for out-licensing (Read more about it here: https://lnkd.in/g5UnVWii) ?? potential collaborations and partnerships Bonus: And, of course, if you're game, let’s grab one of those legendary Malm? falafels together! ???? Not attending? No problem—DM me to schedule a virtual meeting ?? Looking forward to meeting both familiar faces and new ones— Nordic Life Science Days will be epic! ?? #generativeAI #AI #artificialintelligence #AIDD #drugdiscovery #drugdevelopment #lifesciences #healthcare #networking #InsilicoMedicine #NLSDays #Sweden #Nordics #Malm? ??

???? What an epic first day at Aging Research & Drug Discovery Meeting #ARDD2024 ! ?? I've had the pleasure of meeting so many amazing people in the longevity community. If we haven't crossed paths yet, swing by our booth! I'd be happy to show you a live demo of our platforms (PandaOmics , Chemistry42 , inClinico , Precious3GPT ) and chat about how they can supercharge your research. Insilico Medicine Fedor Galkin Stephanie Tsang #ARDD2024 #longevity #agingresearch

?? Meet Insilico Medicine’s team at Aging Research & Drug Discovery Meeting! Our team is on-site and ready to showcase the power of our Pharma.AI platform! Join us for live demo where you can explore how our cutting-edge AI technologies are transforming drug discovery and aging research. This is a rare opportunity to connect directly with our experts, try out our platform, and see firsthand how Pharma.AI can accelerate your research. Let’s connect and drive the future of healthcare together! Alex Zhavoronkov Alex Aliper Frank Pun Jan Szollos, MBA Aisyah Sj?holm, MD, Msc. Fedor Galkin Stephanie Tsang PandaOmics Chemistry42 Precious3GPT inClinico #ARDD2024 #InsilicoMedicine #PharmaAI #agingresearch #drugdiscovery #AIinhealthcare